FDA to Require Boxed Warning for Montelukast

FDA to Require Boxed Warning for Montelukast

By Gary Fitzgerald Allergy & Asthma Network’s voices were heard – the U.S. Food and Drug Administration (FDA) announced it is requiring a boxed warning for montelukast due to mental health, behavior and mood-related changes associated with the medication. “Allergy...

Pin It on Pinterest